Literature DB >> 9801042

North Carolina macular dystrophy (MCDR1) in Texas.

K W Small1, C A Garcia, G Gallardo, N Udar, S Yelchits.   

Abstract

PURPOSE: To map the gene responsible for causing a macular degeneration in a Texan family that appears clinically similar to the North Carolina macular dystrophy (MCDR1) phenotype.
METHODS: A single family in Texas had all the typical clinical features of the North Carolina macular dystrophy phenotype. Of 23 family members examined, 10 were affected. Blood was collected from all 23 members and fundus photographs were obtained on those affected. A detailed family history consisting of nine generations was obtained. Genotyping and likelihood analysis was performed using the closest linked MCDR1 markers.
RESULTS: The genealogic data showed no relation with the original North Carolina macular dystrophy pedigree. The dinucleotide repeat marker D6S283 yielded the highest 2-point LOD score with a Zmax = 4.1 at theta = 0. The peak LOD score generated from multipoint analysis was 6.0.
CONCLUSIONS: The linkage results indicate that the macular degeneration in this Texan family is due to a mutation in the same genomic region as that causing North Carolina macular dystrophy. Furthermore, haplotype analysis suggests that the original North Carolina family and the Texan family have the same mutation and a common founder.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9801042

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  9 in total

Review 1.  Molecular genetics of macular degeneration.

Authors:  M A Musarella
Journal:  Doc Ophthalmol       Date:  2001-05       Impact factor: 2.379

Review 2.  Genotype-phenotype correlations and differential diagnosis in autosomal dominant macular disease.

Authors:  A Iannaccone
Journal:  Doc Ophthalmol       Date:  2001-05       Impact factor: 2.379

3.  Clinical characterization and genetic mapping of North Carolina macular dystrophy.

Authors:  Zhenglin Yang; Zongzhong Tong; Louis J Chorich; Erik Pearson; Xian Yang; Anthony Moore; David M Hunt; Kang Zhang
Journal:  Vision Res       Date:  2007-10-31       Impact factor: 1.886

4.  North Carolina Macular Dystrophy Is Caused by Dysregulation of the Retinal Transcription Factor PRDM13.

Authors:  Kent W Small; Adam P DeLuca; S Scott Whitmore; Thomas Rosenberg; Rosemary Silva-Garcia; Nitin Udar; Bernard Puech; Charles A Garcia; Thomas A Rice; Gerald A Fishman; Elise Héon; James C Folk; Luan M Streb; Christine M Haas; Luke A Wiley; Todd E Scheetz; John H Fingert; Robert F Mullins; Budd A Tucker; Edwin M Stone
Journal:  Ophthalmology       Date:  2015-10-24       Impact factor: 12.079

5.  A Korean family with an early-onset autosomal dominant macular dystrophy resembling North Carolina macular dystrophy.

Authors:  Sang Jin Kim; Se Joon Woo; Hyeong Gon Yu
Journal:  Korean J Ophthalmol       Date:  2006-12

6.  North Carolina macular dystrophy (MCDR1) caused by a novel tandem duplication of the PRDM13 gene.

Authors:  Sara J Bowne; Lori S Sullivan; Dianna K Wheaton; Kirsten G Locke; Kaylie D Jones; Daniel C Koboldt; Robert S Fulton; Richard K Wilson; Susan H Blanton; David G Birch; Stephen P Daiger
Journal:  Mol Vis       Date:  2016-10-17       Impact factor: 2.367

7.  Duplication events downstream of IRX1 cause North Carolina macular dystrophy at the MCDR3 locus.

Authors:  Valentina Cipriani; Raquel S Silva; Gavin Arno; Nikolas Pontikos; Ambreen Kalhoro; Sandra Valeina; Inna Inashkina; Mareta Audere; Katrina Rutka; Bernard Puech; Michel Michaelides; Veronica van Heyningen; Baiba Lace; Andrew R Webster; Anthony T Moore
Journal:  Sci Rep       Date:  2017-08-08       Impact factor: 4.379

8.  A unique PRDM13-associated variant in a Georgian Jewish family with probable North Carolina macular dystrophy and the possible contribution of a unique CFH variant.

Authors:  Prasanthi Namburi; Samer Khateb; Segev Meyer; Tom Bentovim; Rinki Ratnapriya; Alisa Khramushin; Anand Swaroop; Ora Schueler-Furman; Eyal Banin; Dror Sharon
Journal:  Mol Vis       Date:  2020-04-16       Impact factor: 2.367

9.  A novel duplication involving PRDM13 in a Turkish family supports its role in North Carolina macular dystrophy (NCMD/MCDR1).

Authors:  Kent W Small; Stijn Van de Sompele; Karen Nuytemans; Andrea Vincent; Ozge Ozalp Yuregir; Emine Ciloglu; Cahfer Sariyildiz; Toon Rosseel; Jessica Avetisjan; Nitin Udar; Jeffery M Vance; Margaret A Pericak-Vance; Elfride De Baere; Fadi S Shaya
Journal:  Mol Vis       Date:  2021-09-01       Impact factor: 2.367

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.